Publication at Faculty of Medicine in Hradec Králové |
2010
Abstract
Surgery is the fundamental treatment of renal cell carcinoma. About 10-20 % of patients have response to cytokines, interferon alfa a interleukin-2.
Antiangiogenic therapy is file into the first line of the treatment on the basis of new studies.